Monte Rosa Therapeutics
GLUE
NASDAQ
IPO2021
about GLUE
Monte Rosa Therapeutics is a biotech company focused on precision medicine, particularly in immuno-oncology, using advanced computational methods like machine learning and genomics to identify novel cancer targets and develop innovative antibody-based therapeutic treatments.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $23.36 | $25.77 | $22.77 | $1.5B | 3.53M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | 162.95 | -258.26% | -212.10% | 0% |